Further Reading Read more GLP-1 Wellness Program Read Dr Glenn Lyles Blog about Can I Have Plastic Surgery While Taking Semaglutide or Tirzepatide
In DECLARE-TIMI58 with dapagliflozin, 4.4% of the patients were using GLP-1RAs at baseline, and dapagliflozin reduced the risks of MACE, HHF, and composite kidney outcomes regardless of baseline GLP-1RA use [49]
If the main drivers are stress physiology, under-eating, gut inflammation, thyroid dysfunction, nutrient deficiencies, sleep disruption, or adrenal dysregulation, appetite suppression is not the best first move and may do harm
For many individuals, this price puts treatment out of reach